Avidity Biosciences, Inc. (NASDAQ:RNA) Given Average Rating

Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) has earned an average recommendation of “Buy” from the six brokerages that are presently covering the stock, Marketbeat reports. Five equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1-year price objective […]

Related Keywords

Arizona , United States , American , , Daiwa Securities Group Inc , American International Group Inc , Avidity Biosciences Inc , Nasdaq , Ameritas Investment Partners Inc , Credit Suisse Group , Avidity Biosciences Company Profile , Group Plc , Wells Fargo Company , Avidity Biosciences , Get Free Report , Suisse Group , General Group Plc , State Retirement System , Securities Group , Investment Partners , American International Group , International Group , Get Free , Avidity Biosciences Daily , Nasdaq Rna , Rna , Medical , Ratings , Consensus ,